XML 20 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating Activities:    
Net loss $ (15,939) $ (8,722)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 342 555
Bad debt expense (21) 217
Inventory reserve 1,599 382
Realized foreign exchange (gain) loss 107 (128)
Stock based compensation 1,334 739
Amortization of stock-based marketing services shares issued for services 910 185
Amortization of debt finance costs 1,801 492
Other (10)
Effect of changes in assets and liabilities:    
Accounts receivable, net 160 (238)
Inventories, net (937) (349)
Prepaid and other current assets (1,493) (219)
Operating lease right-of-use assets 99 268
Other non-current assets 3 (37)
Operating lease right-of-use liability (100) (162)
Trade payables 903 295
Accrued expenses 1,536 2,029
Unearned revenue (155) 240
Net cash used in operating activities (9,861) (4,453)
Investing Activities:    
Purchases of property and equipment (302) (211)
Net cash used by investing activities (302) (211)
Financing Activities:    
Proceeds from initial public offering 6,009
Proceeds from sale of common stock 2,179
Proceeds from issuance of preference shares and warrants, net 5,148
Proceeds from convertible debt obligations 2,000
Proceeds from trade finance facility 2,845 1,847
Repayment of trade finance facility (351) (1,873)
Proceeds from short-term borrowings, net 5,792
Repayment of short-term borrowings (5,742)
Net cash provided by financing activities 9,692 8,162
Effect of Exchange Rate Changes on Cash 70 (300)
Net change in cash (401) 3,198
Cash and cash equivalents and restricted cash - beginning of period 7,910 4,712
Cash and cash equivalents and restricted cash - end of period 7,509 7,910
Supplemental disclosures of cash flow information:    
Interest paid on borrowings and bank loans 154 107
Reconciliation of cash, cash equivalents, and restricted cash reported in the consolidated balance sheets    
Cash and cash equivalents 6,159 7,910
Restricted cash 1,350
Total cash, cash equivalents and restricted cash presented in the consolidated statements of cash flows 7,509 7,910
Supplemental disclosure of non-cash investing and financing activities:    
Conversion of convertible debt to common stock 2,000 11,987
Fair value of shares issued in exchange for services to be received 1,488
Recognition of debt discounts on short-term borrowings 2,866
Offset of deferred offering costs to proceeds received 1,169
Recognition of operating lease right of use assets and lease obligations 198
Write-off of expired operating lease right-of-use assets and lease obligations $ 53